Free Trial
CVE:VIR

Viridium Pacific Group (VIR) Stock Price, News & Analysis

Viridium Pacific Group logo
C$0.38 +0.02 (+5.56%)
As of 06/7/2019

About Viridium Pacific Group Stock (CVE:VIR)

Key Stats

Today's Range
C$0.37
C$0.41
50-Day Range
C$0.38
C$0.38
52-Week Range
C$0.36
C$1.15
Volume
26,500 shs
Average Volume
92,632 shs
Market Capitalization
C$37.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Remove Ads
Receive VIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter.

VIR Stock News Headlines

Feds Just Admitted It—They Can Take Your Cash
The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.
Pacific American Holdings Acquires Promising Silver Project
Pacific Urban Investors acquires Cupertino apartments
See More Headlines

VIR Stock Analysis - Frequently Asked Questions

Viridium Pacific Group's stock was trading at C$0.38 on January 1st, 2025. Since then, VIR stock has increased by 0.0% and is now trading at C$0.38.
View the best growth stocks for 2025 here
.

Shares of VIR stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viridium Pacific Group investors own include Baytex Energy (BTE), Allena Pharmaceuticals (ALNA), Abacus Health Products (ABAHF), Aurora Cannabis (ACBFF), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS) and Ardelyx (ARDX).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:VIR
CIK
N/A
Fax
N/A
Employees
580
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.09 million
Cash Flow
C$0.13 per share
Price / Cash Flow
2.92
Book Value
C$0.29 per share
Price / Book
1.30

Miscellaneous

Free Float
N/A
Market Cap
C$37.52 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:VIR) was last updated on 4/6/2025 by MarketBeat.com Staff
From Our Partners